Rob Stein
Rob Stein
Rob Stein is a correspondent/senior editor at NPR, focusing on health, medicine and biomedical research.Source
Washington, DC
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
1 reviews

RECENT ARTICLES

Sort by:
No Rating
As Cities Hit Hardest By COVID-19 Reopen, Red Flags Emerge In Other Areas

As Cities Hit Hardest By COVID-19 Reopen, Red Flags Emerge In Other Areas

As Cities Hit Hardest By COVID-19 Reopen, Red Flags Emerge In Other Areas Troubling signs are emerging that new coronavirus hot spots may have started to erupt around the United States as the country has begun to reopen.Heard onToggle more optionsTroubling signs are emerging that new coronavirus hot spots may have started to erupt around the United States as the country has begun to reopen.DAVID GREENE, HOST:Maybe you don't need this reminder because you're still on some kind of stay-at-home order. Or maybe you do need it because life feels like it's back to normal in your part of the...

June 10, 2020
Share
Save
Review
No Rating
Experts Fear Mass Protests May Cause New Coronavirus Outbreaks Around The U.S.

Experts Fear Mass Protests May Cause New Coronavirus Outbreaks Around The U.S.

Experts Fear Mass Protests May Cause New Coronavirus Outbreaks Around The U.S. Protests over George Floyd's death continue sweeping across the U.S., creating new dangers. Public health experts fear the coronavirus could begin erupting in new outbreaks around the country.Heard onToggle more optionsProtests over George Floyd's death continue sweeping across the U.S., creating new dangers. Public health experts fear the coronavirus could begin erupting in new outbreaks around the country.MARY LOUISE KELLY, HOST:The United States has entered a dangerous new phase in the fight against the...

June 2, 2020
Share
Save
Review
No Rating
A Year In, 1st Patient To Get Gene Editing For Sickle Cell Disease Is Thriving

A Year In, 1st Patient To Get Gene Editing For Sickle Cell Disease Is Thriving

Experimental CRISPR Treatment For Sickle Cell Disease Appears Effective : Shots - Health News Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.Heard onToggle more optionsLike millions of other Americans, Victoria Gray has been sheltering at home with her children as the U.S. struggles through a deadly pandemic, and as protests over police violence have erupted across the country. But Gray is not like any other American. She's the first person with a genetic...

June 23, 2020
Share
Save
Review
No Rating
Antibody Testing Is Increasing, But A Positive Result Doesn't Prove Immunity

Antibody Testing Is Increasing, But A Positive Result Doesn't Prove Immunity

Antibody Testing Is Increasing, But A Positive Result Doesn't Prove Immunity As more people get tested for antibodies to the coronavirus, fears rise that they'll let down their guard mistakenly believing antibodies guarantee protection.Heard onToggle more optionsAs more people get tested for antibodies to the coronavirus, fears rise that they'll let down their guard mistakenly believing antibodies guarantee protection.SCOTT SIMON, HOST:More people are seeking out antibody tests to see if they've developed immunity to the coronavirus. But while those tests can offer some peace of mind, they...

May 23, 2020
Share
Save
Review
No Rating
Study Raises Questions About False Negatives From Quick COVID-19 Test

Study Raises Questions About False Negatives From Quick COVID-19 Test

Study Raises Questions About False Negatives From Quick COVID-19 Test : Shots - Health News New research suggests the Abbott ID NOW test, which produces results in less than 15 minutes, is the most likely among common tests to reassure people they are not infected when they really are.Heard onToggle more optionsThe fastest test being used to diagnose people infected with the coronavirus appears to be the least accurate test now in common use, according to new research obtained by NPR. Researchers at the Cleveland Clinic tested 239 specimens known to contain the coronavirus using five of the...

April 21, 2020
Share
Save
Review
No Rating
Antigen Test For COVID-19 Isn't As Reliable As Genetic Test, Experts Caution

Antigen Test For COVID-19 Isn't As Reliable As Genetic Test, Experts Caution

Antigen Test For COVID-19 Isn't As Reliable As Genetic Test, Experts Caution Doctors are using a new antigen test that is a faster method to spot people infected with the coronavirus. It's cheaper and simpler but may be less reliable.Heard onToggle more optionsDoctors are using a new antigen test that is a faster method to spot people infected with the coronavirus. It's cheaper and simpler but may be less reliable.DAVID GREENE, HOST:All right, so there's this new kind of test for the coronavirus. It is fast, and it is also easier to use than the one most people have been getting. And with...

July 8, 2020
Share
Save
Review
No Rating
FDA Worries COVID-19 Test Misses Too Many People Who Are Infected

FDA Worries COVID-19 Test Misses Too Many People Who Are Infected

FDA Worries COVID-19 Test Misses Too Many People Who Are Infected The Food And Drug Administration is raising concerns about the accuracy of the Abbott ID Now Coronavirus test, which returns results within 15 minutes. The FDA worries about false negative results.Heard onToggle more optionsThe Food And Drug Administration is raising concerns about the accuracy of the Abbott ID Now Coronavirus test, which returns results within 15 minutes. The FDA worries about false negative results.STEVE INSKEEP, HOST:Is a coronavirus test that the president promoted reliable? The Abbott ID Now test is a...

May 15, 2020
Share
Save
Review
No Rating
CDC Director: 'Very Aggressive' Contact Tracing Needed For U.S. To Return To Normal

CDC Director: 'Very Aggressive' Contact Tracing Needed For U.S. To Return To Normal

What Will It Take To Reopen U.S.? CDC Says 'Aggressive' Contact Tracing : Shots - Health News We're in shutdown mode for now, but what comes next? Robert Redfield, director of the Centers for Disease Control and Prevention, is working on a plan to safely reopen the country.Heard onToggle more optionsIt's the question on everyone's minds: What will it take for us to come out of this period of extreme social distancing and return to some semblance of normal life? It turns out that the Centers for Disease Control and Prevention has been working on a plan to allow the U.S. to safely begin to...

April 10, 2020
Share
Save
Review
OUTLETS
npr.org

npr.org

CRITIC
img-trusted
94%
PUBLIC
img-trusted
86%